Skip to main navigation Skip to search Skip to main content

Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

  • C Thieblemont
  • , S Howlett
  • , RO Casasnovas
  • , N Mounier
  • , A Perrot
  • , F Morschhauser
  • , C Fruchart
  • , N Daguindau
  • , K van Eygen
  • , L Oberic
  • , R Bouabdallah
  • , GM Pica
  • , E Nicolas-Virezelier
  • , J Abraham
  • , O Fitoussi
  • , S Snauwaert
  • , JC Eisenmann
  • , P Lionne-Huyghe
  • , D Bron
  • , S Tricot
  • D Deeren, H Gonzalez, R Costello, K Le Du, MG da Silva, S Grosicki, J Trotman, J Catalano, D Caballero, Richard Greil (Co-author), AM Cohen, P Gaulard, L Roulin, K Takeshita, ML Casadebaig, H Tilly, B Coiffier

Research output: Contribution to journalOriginal Articlepeer-review

17 Citations (Web of Science)
Original languageEnglish
JournalBRITISH JOURNAL OF HAEMATOLOGY
DOIs
Publication statusPublished - 2019

Keywords

  • CLINICAL-TRIALS
  • TRANSPLANTATION
  • THERAPY
  • RITUXIMAB
  • SURVIVORS

Cite this